Award

Delivery Order #SPE2DR26FCSE6

Delivery Order for Nucala Auto-Injector from DMS Pharmaceutical Group

Buyer

Defense Logistics Agency

Award Amount

$3,863.68

Ceiling

$3,863.68

Awarded

March 11, 2026

Period of Performance

Mar 11, 2026 – Mar 12, 2026

Identifier

SPE2DR26FCSE6

NAICS

424210

This award is a delivery order contract issued to DMS Pharmaceutical Group Inc., a pharmaceutical distributor specializing in healthcare solutions. The contract procures a specific pharmaceutical product, the Nucala 100 mg/ml auto-injector, intended to support ongoing health initiatives requiring this medication. The award is significant as it ensures timely access to critical pharmaceutical products required by the agency, reinforcing continuous support for patient care. The scope includes the delivery of the specified Nucala auto-injector in a short performance window, demonstrating the agency's need for swift fulfillment of this healthcare supply. This delivery order is tied to a larger, long-term definitive contract previously awarded to DMS Pharmaceutical Group, indicating continuity and reliability in pharmaceutical procurement. The award was competitively procured under the existing contract umbrella, and the short timeline for delivery emphasizes prompt service. The contract performance period spans a single day, reflecting the urgent and specific nature of this pharmaceutical requirement.

Description

4571128595!NUCALA 100 MG/ML AUTO-INJECTORML

View original record